{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:57:10Z","timestamp":1782766630914,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"USDA (2008-03776)"},{"name":"Montana Agricultural Station"},{"name":"USDA Formula Funds"},{"name":"NIH\/NCRR COBRE"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.vaccine.2009.10.113","type":"journal-article","created":{"date-parts":[[2009,11,14]],"date-time":"2009-11-14T10:03:52Z","timestamp":1258193032000},"page":"1069-1074","source":"Crossref","is-referenced-by-count":18,"title":["\u0394znuA\u0394purE Brucella abortus 2308 mutant as a live vaccine candidate"],"prefix":"10.1016","volume":"28","author":[{"given":"Xinghong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Thornburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.10.113_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.10.113_bib2","first-page":"981270","article-title":"Brucellosis\u2014new aspects of an old disease","author":"Cutler","year":"2005","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2009.10.113_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1051\/vetres:2005003","article-title":"From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis","volume":"36","author":"Godfroid","year":"2005","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2009.10.113_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/030098588902600609","article-title":"Intracellular localization of Brucella abortus in bovine placenta","volume":"26","author":"Meador","year":"1989","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2009.10.113_bib5","series-title":"Animal brucellosis","first-page":"301","article-title":"The pathogenesis and pathobiology of Brucella infection in domestic animals","author":"Enright","year":"1990"},{"key":"10.1016\/j.vaccine.2009.10.113_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/030098589102800605","article-title":"Brucella abortus-associated meningitis in aborted bovine fetuses","volume":"28","author":"Hong","year":"1991","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2009.10.113_bib7","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1098\/rstb.2009.0086","article-title":"Wild boars as sources for infectious diseases in livestock and humans","volume":"364","author":"Meng","year":"2009","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2009.10.113_bib8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/IAI.01017-08","article-title":"The Brucella abortus S19 \u0394vjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB\/c mice when delivered in a sustained-release vehicle","volume":"77","author":"Arenas-Gamboa","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2003037","article-title":"Rough vaccines in animal brucellosis: structural and genetic basis and present status","volume":"35","author":"Moriyon","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2009.10.113_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-5877(96)01110-5","article-title":"A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats","volume":"31","author":"Blasco","year":"1997","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2009.10.113_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1469-0691.2008.02029.x","article-title":"Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina","volume":"14","author":"Wallach","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2009.10.113_bib12","first-page":"147","article-title":"Vaccination against Brucella","volume":"13","author":"Nicoletti","year":"1990","journal-title":"Adv Biotechnol Processes"},{"key":"10.1016\/j.vaccine.2009.10.113_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2009.10.113_bib14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2460\/ajvr.1998.59.08.1016","article-title":"Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence","volume":"59","author":"Lord","year":"1998","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2009.10.113_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-1135(91)90091-S","article-title":"Biological properties of RB51\u2014a stable rough strain of Brucella abortus","volume":"28","author":"Schurig","year":"1991","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2009.10.113_bib16","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/IAI.73.7.4198-4204.2005","article-title":"Protective properties of rifampin-resistant rough mutants of Brucella melitensis","volume":"73","author":"Adone","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2460\/ajvr.1996.57.08.1153","article-title":"Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis","volume":"57","author":"Cheville","year":"1996","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2009.10.113_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1053\/rvsc.1998.0251","article-title":"Responses of cattle to two dosages of Brucella abortus strain RB51: serology, clearance and efficacy","volume":"66","author":"Olsen","year":"1999","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2009.10.113_bib19","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2460\/ajvr.1998.59.12.1575","article-title":"Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51","volume":"59","author":"Elzer","year":"1998","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2009.10.113_bib20","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1016\/j.vaccine.2006.04.020","article-title":"Efficacy of strain RB51 vaccine in heifers against experimental brucellosis","volume":"24","author":"Poester","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.10.113_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0021-9975(67)90021-7","article-title":"Effect of living Rev 1 vaccine in producing long-term immunity against Brucella melitensis infection in sheep in Iran","volume":"77","author":"Entessar","year":"1967","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2009.10.113_bib22","series-title":"Wyoming brucellosis coordination team report and recommendations","author":"Galey","year":"2005"},{"key":"10.1016\/j.vaccine.2009.10.113_bib23","unstructured":"USDA:APHIS. 2007 animal health report; 2008."},{"key":"10.1016\/j.vaccine.2009.10.113_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1292\/jvms.66.1059","article-title":"Zinc uptake system (znuA locus) of Brucella abortus is essential for intracellular survival and virulence in mice","volume":"66","author":"Kim","year":"2004","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2009.10.113_bib25","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1128\/IAI.01957-05","article-title":"Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge","volume":"74","author":"Yang","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib26","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/IAI.72.8.4911-4917.2004","article-title":"Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB\/c mouse model","volume":"72","author":"Alcantara","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib27","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/IAI.71.6.3261-3271.2003","article-title":"Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model","volume":"71","author":"Monreal","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib28","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1128\/IAI.62.8.3206-3212.1994","article-title":"Immune and pathological responses in mice infected with Brucella abortus-19 Brucella abortus-RB51, or Brucella abortus-2308","volume":"62","author":"Stevens","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib29","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1128\/IAI.64.6.2188-2192.1996","article-title":"Deletion of purE attenuates Brucella melitensis infection in mice","volume":"64","author":"Crawford","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/IAI.69.2.865-868.2001","article-title":"Gene discovery through genomic sequencing of Brucella abortus","volume":"69","author":"Sanchez","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib31","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1128\/JB.187.8.2715-2726.2005","article-title":"Completion of the genome sequence of Brucella abortus and comparison to the highly similar genomes of Brucella melitensis and Brucella suis","volume":"187","author":"Halling","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2009.10.113_bib32","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1046\/j.1365-2958.1998.00883.x","article-title":"The znuABC high-affinity zinc uptake system and its regulator Zur in Escherichia coli","volume":"28","author":"Patzer","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2009.10.113_bib33","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2460\/ajvr.1988.49.07.1092","article-title":"Survival of rough and smooth strains of Brucella abortus in bovine mammary gland macrophages","volume":"49","author":"Harmon","year":"1998","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2009.10.113_bib34","first-page":"197","article-title":"Interactions between professional phagocytes and Brucella spp.","volume":"12","author":"Liautard","year":"1996","journal-title":"Microbiologia"},{"key":"10.1016\/j.vaccine.2009.10.113_bib35","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1128\/IAI.73.5.2873-2880.2005","article-title":"The Brucella abortus Cu, Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice","volume":"73","author":"Gee","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib36","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/IAI.64.7.2431-2439.1996","article-title":"Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensis","volume":"64","author":"Cheville","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib37","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1128\/IAI.67.11.5877-5884.1999","article-title":"Protection of mice against brucellosis by vaccination with Brucella melitensis WR201 (16M \u0394purEK)","volume":"67","author":"Hoover","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.113_bib38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CMR.16.1.65-78.2003","article-title":"Molecular host\u2013pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans","volume":"16","author":"Ko","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2009.10.113_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/biol.2000.0249","article-title":"In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines","volume":"28","author":"Grillo","year":"2000","journal-title":"Biologic"},{"key":"10.1016\/j.vaccine.2009.10.113_bib40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/IAI.63.1.264-270.1995","article-title":"Comparison of immune-responses and resistance to brucellosis in mice vaccinated with Brucella abortus-19 or RB51","volume":"63","author":"Stevens","year":"1995","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09016648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09016648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T06:49:15Z","timestamp":1739429355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09016648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0264410X09016648"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.113","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}